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1. Introduction 
In a bile fistula rat the daily production of bile 
acids is ten to fifteen times greater than in an intact 
rat [ I] . In a previous communication [2] the effect 
of biliary drainage on some reactions in the conver- 
sion of cholesterol into taurocholic acid was studied. 
It was found that the increase in bile acid formation 
in the bile fistula rat was parallelled by an increase in 
the 7a-hydroxylation of cholesterol. The other reac- 
tions studied, the conversion of cholest-5_ene-3&7u- 
diol into 7u-hydroxycholest4en3_one, the 12u-hy- 
droxylation of 7u-hydroxycholest4er+3_one, and the 
7a-hydroxylation of taurodeoxycholic acid, were 
influenced much less by biliary drainage. It was sug- 
gested that the formation of cholest-5ene-3&7u-do1 
from cholesterol might be a rate-determining step in 
the conversion of cholesterol into bile acids. However, 
no conclusions could be drawn concerning the nature 
of the increase in activity of the 7u-hydroxylating en- 
zyme system. It was shown that the increase in enzyme 
activity was not due to any general increase in liver 
protein. An increase in enzyme activity might depend 
on (1) an activation of preexisting enzyme, (2) an in- 
duced increase in the synthesis of the enzyme and/or 
(3) a decrease in the breakdown of the enzyme. Ac- 
cording to current concepts [3] the rate of synthesis 
may be the preferential way of the mammalian or- 
ganism to control its levels of enzyme activity. During 
recent years specific inhibitors of protein synthesis 
have been used in studies of the mechanisms involved 
in increased enzyme activity. Thus, actinomycin D, 
North-Holland Publishing Company - Amsterdam 
which inhibits the DNA-dependent synthesis of RNA 
[4], and puromycin, which interferes with the trans- 
fer of amino acids to ribosomes [5], have been used 
in studies of’for instance tryptophan pyrrolase [6,7] 
and &aminolevulinic acid synthetase [8]. To obtain 
some information on the mechanisms of the increased 
formation of cholest-5ene-3/_$7udiol fr m cholesterol, 
induced by biliary drainage, actinomycin D and puro- 
mycin were given to bile fistula rats, and,the effect on 
the 7u-hydroxylation of cholesterol, armfor compart 
son, on the conversion of cholest-5ene-3&7adiol into 
7u-hydroxycholest4-en3-one and on the 12u-hydrox- 
ylation of 7u-hydroxycholest4en3-one was studied. 
2. Materials and methods 
4-14C-cholesterol (specific radioactivity, 145 PC/ 
mg) was obtained from Radiochemical Centre, Am- 
ersham, England. Prior to use, the labeled cholesterol 
was purified by chromatography on a column of alu- 
minum oxide, grade I (Woelm, Eschwege, Germany). 
7~3H-Cholest-5ene-3&7adiol (specific radioactivity, 
10 &/mg) and tritium-labeled 7a-hydroxycholest4 
en-3one (specific radioactivity, 10 &/mg) were pre- 
pared as described previously [9, lo]. NAD, NADPH 
and puromycin (dihydrochloride, grade II) were ob- 
tained from Sigma Chemical Co., St. Louis, MO. Acti- 
nomycin D was a gift from Merck, Sharp & Dohme 
Res. Lab., Rahway, N. J. 
White male rats of the Sprague-Dawley strain 
weighing 150-200 g were used. The bile fistula opera- 
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tion was performed in the usual manner and the bile 
fistula rats were kept in restraining cages. They were 
given 0.9% solution of sodium chloride to drink and 
had free access to a chow diet. Actinomycin D and 
puromycin, dissolved in 1 ml of saline, were adminis- 
tered by intraperitoneal injection. The control rats 
were given the same amount of saline. Liver homo- 
genates, 20%, were prepared in a modified Bucher 
medium [1 l] with a .Potter-Elvehjem homogenizer 
using a loosely fitting teflon pestle. The 20000 X g 
supernatant fluid and the microsomal fraction were 
prepared as described in a previous communication 
[2]. The labeled compounds were added to the incu- 
bation mixtures dissolved in 50 ~1 of acetone. 4-14C- 
Cholesterol, 10 pg, was incubated with 3 ml of 
20000 X g supernatant fluid, diluted with 2 ml of 
Bucher medium, for 1 hour at 37”. 7@H-Cholest-5- 
ene-3&7a-diol, 40 pg, was added to a mixture of 1 ml 
of microsomal fraction, 2 ml of Bucher medium and 
1 pmole of NAD, and incubation was carried out for 
20 min at 37”. Tritium-labeled 7a-hydroxycholest4 
en-3-one, 80 pg, was incubated with 3 ml of micro- 
somal fraction fortified with 3 wales of NADPH for 
10 min at 37’. Termination of the incubations and 
further analysis were carried out as described in a 
previous communication [2]. 
Bile fistula rats were given a single injection of ao 
tinomycin D (500 pg/kg body weight) or puromycin 
(100 mg/kg body weight) 72 hours after operation, 
when the activity of the 7u-hydroxylase, catalyzing 
the conversion of cholesterol into cholest-5_ene3& 
7a-diol, has reached aplateau. After 1 - 7.5 hours the 
rats were killed and the extent of conversion of cho- 
lesterol into 7u-hydroxylated products was determined. 
For comparison, the extent of conversion of cholestd- 
ene-3/3,7a-dial into 7a-hydroxycholest4en3-one and 
the 12a-hydroxylation of 7u-hydroxycholest4en3- 
one were determined. No marked differences were ob- 
served between the rats with respect o the pattern of 
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Radioactivity was determined with a methane gas 
flow counter. Under the conditions of the assay 1 PC 
of 14C corresponds to 1 X lo6 cpm and 1 /.Z of 3H 
to 6 X lo5 cpm. 
3. Results and discussion START 
Four bile fistula rats were given three injections of 
actinomycin D (100 Mg/kg body weight) at 12,24 and 
36 hours after operation. The animals were killed after 
48 hours. Three control rats were injected in the same 
way with saline. The conversion of cholesterol into 7u- 
hydroxylated products (cholest-S-ene-3fi,7a-diol, 7u- 
hydroxycholest4en3_one, and 7a,l2a-dihydroxy- 
cholest4en3-one) was on an average 4.4% (range, 
3.2 - 5.6%) in the control rats and 0.9% (range 0.4- 
1.5%) in the actinomycin D-treated rats. No marked 
differences were observed with respect o the pattern 
of products formed between control rats and actino- 
mycin D-treated rats. Actinomycin D thus prevented 
an increase of the 7a-hydroxylating activity in bile 
tistula rats. 
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Fig. 1. A, thin layer chromatogram of chloroform extract of 
incubation of 4.14Ccholestero1,lO ng, with the 2OOOOxg 
supernatant fluid of homogenate of liver from bile fistula 
rat. The numbers on the chromatogram represent cpm. Ref- 
erence compounds were: 1, Sp-cholestane-3a,7a,lZa-triol; 2, 
7a,l2a-dihydroxycholest-44-en-3-one; 3, cholest-Sene-3p, 
7a-diol; 4, cholestJ-ene-3p,7p-diol; 5, Ila-hydroxycholest- 
4-en-3-one; 6, cholesterol. Solvent, benzene-ethyl acetate 
(2 : 3). B, thin layer chromatogram of chloroform extract 
of incubation of 4-14C-cholesterol, 10 Mg, with the 
20000x g supematant fluid of homogenate of liver from 
bile fistula rat injected with puromycin 4 hours before 
sacrifice. Reference compounds and chromatographic 
I 7.800 I 2.000 
conditions as in A. 
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Fig. 2. Effect of actinomycin D on some reactions in the con- 
version of cholesterol into.chohc acid in homogenates of liver 
from bile fistula rats. e-e, conversion of CL4Ccholesterol 
into 7a-hydroxylated products (cholestJ-ene-3&7a-diol, 7a- 
hydroxycholesG&en-3-one, and 7~,12a_dihydroxycholest-4- 
en-3-one) in the presence of 20000 X g supernatant fluid. 
O---O, conversion of 7@-3H-cholest-Sene-3p,7a-diol into 7a- 
hydroxycholest-4+n-3-one in the presence of microsomal 
fraction fortified with NAD. c-o, conversion of tritium- 
labeled 7a-hydroxycholes+&en-3-one i to 7a,l2a_dihydroxy- 
cholest-4-en-3-one in the presence of microsomal fraction for- 
tified with NADPH. 
products formed (cf. fig. 1). After treatment with ac- 
tinomycin D, the activity of the 7u-hydroxylase de- 
creased rapidly (fig. 2), indicating that the 7u-hydrox- 
ylase and its messenger-RNA have short half-life times 
in the bile fistula rat [ 121. The half-life time for the 
breakdown of the 7a-hydroxylase was calculated to 
be 2-3 hours from the experiments with puromycin 
(fig. 3). No significant decrease in the conversion of 
cholest-5-ene-3f3,7u-diol int  7a_hydroxycholest4en- 
3-one or in the 12u-hydroxylation of 7a_hydroxy- 
cholest4en3-one could be seen after treatment with 
actinomycin D (fig. 2) or with puromycin (fig. 3), in- 
dicating a longer half-life time for these enzymes than 
for the 7u-hydroxylase. 
The increase in the activity of the 7u-hydroxylase 
in the bile fistula rat may depend on an increased en- 
zyme synthesis or on a diminished rate of breakdown 
of the enzyme. The data presented o not exclude the 
possibility of a decrease in breakdown of the enzyme 
but this would mean that the half-life time of the en- 
zyme should be even shorter in the intact rat, which 
seems improbable. It should also be pointed out that 
the preferential way of the mammalian organism to 




Fig. 3. Effect of puromycin on some reactions in the conver- 
sion of cholesterol into cholic acid in homogenates of liver 
from bile fistula rats. Symbols as in fig. 2. 
zyme synthesis [3]. The half-life time for the break- 
down of the 7u-hydroxylase in the bile fistula rat was 
calculated to be 2-3 hours, whereas the half-life time 
for total liver protein is 2-3 days [ 131. It has been sug- 
gested that inducible liver enzymes will have half-life 
times of the order of a few hours, whereas noninducible 
enzymes have much longer half-life times [ 141. The 
present results are also consistent with the view that 
the conversion of cholesterol into cholest+ene-3&7u- 
diol is a rate-determining step in the biosynthesis of 
bile acids from cholesterol. 
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